Calamos Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Calamos Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$740K	Buy	+51,559	New	+$766K	﹤0.01%	844

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Calamos Advisors's BMEZ Position: Q1 2026 in Review

Calamos Advisors opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q1 2026: 51,559 shares worth $740K. The stake represents ﹤0.01% of the portfolio and ranks #844 among its holdings.

88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

Calamos Advisors held 51,559 shares of BlackRock Health Sciences Trust II worth $740K as of Q1 2026.
BlackRock Health Sciences Trust II was a new Calamos Advisors position in Q1 2026.
BlackRock Health Sciences Trust II made up ﹤0.01% of Calamos Advisors's portfolio in Q1 2026, its #844 holding.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.